immagine del profilo
I'm not @Tenbagger2024 but I'll take the liberty of saying what I think of the company:

Delcath Systems addresses a clearly defined, medically relevant market with its specialized oncology platform. I find the combination of regulatory progress, a clear clinical niche and the potential for scalable sales really interesting. I don't "yet" have a share like this in my portfolio. If commercialization proceeds as planned, I see an interesting growth story here with an attractive risk/reward profile.
However, the problem or concern for me remains, as is the case with health and pharmaceutical companies, that if a study or treatment is not successful, this can absolutely depress the share price. So it's not a no brainer or a guarantee (even if you don't have this guarantee with any company in the world) that the company will be successful in the future, even if the forecasts and analyst assessments are initially very positive and bullish.
Nevertheless, I am also planning to invest in the near future.
•
6
•
immagine del profilo
@der_Don Thank you! Any opinion is of course welcome...
The risk with regulation is there of course, but its main driver for the next few years is already approved as far as I understand, right?
••
immagine del profilo
@der_Don
Huhu. Everyone was also asked for his opinion
•
1
•
immagine del profilo
@Tenbagger2024 I edited this afterwards 🙈
•
1
•